威尔药业 - Financials

威尔药业 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014
+Revenue	1.3B	1.2B	1.1B	1.0B	736.0M	881.0M	801.0M	694.0M	558.0M	499.0M	528.0M
Revenue Growth %	12.2%	4.1%	6.6%	41.6%	-16.5%	10.0%	15.4%	24.4%	11.8%	-5.5%	--
Total Revenue	1.3B	1.2B	1.1B	1.0B	736.0M	881.0M	801.0M	694.0M	558.0M	499.0M	528.0M
Cost Of Revenue	929.0M	839.0M	808.0M	748.0M	484.0M	578.0M	552.0M	452.0M	334.0M	339.0M	393.0M
+Gross Profit	368.0M	317.0M	303.0M	294.0M	252.0M	303.0M	249.0M	242.0M	224.0M	160.0M	135.0M
Gross Margin %	28.4%	27.4%	27.3%	28.2%	34.2%	34.4%	31.1%	34.9%	40.1%	32.1%	25.6%
Total Operating Cost	1.1B	1.0B	1.0B	927.0M	633.0M	733.0M	682.0M	574.0M	460.0M	427.0M	475.0M
Selling Expenses	14.5M	12.8M	10.9M	13.5M	9.8M	34.4M	31.0M	28.3M	20.6M	19.3M	19.5M
Admin Expenses	101.0M	109.0M	115.0M	106.0M	89.4M	76.5M	61.8M	59.3M	96.2M	56.6M	52.1M
Rd Expenses	71.6M	55.6M	53.9M	41.5M	36.6M	32.9M	24.7M	23.3M	--	--	--
Finance Expenses	11.8M	14.2M	9.5M	7.2M	5.2M	3.5M	6.1M	5.3M	3.9M	7.9M	8.7M
+Operating Income	172.0M	122.0M	113.0M	120.0M	119.0M	157.0M	128.0M	126.0M	98.4M	71.6M	52.5M
Operating Margin %	13.3%	10.6%	10.2%	11.5%	16.2%	17.8%	16.0%	18.2%	17.6%	14.4%	10.0%
Non Operating Income	--	18,900	12,700	52,400	417,900	--	3.8M	--	1.6M	896,600	468,400
Non Operating Expenses	219,200	354,200	391,600	1.1M	1.0M	3.0M	357,000	222,300	9.4M	412,000	434,100
Investment Income	-68,900	100.03	-166,800	543,800	7.7M	5.0M	--	38,300	--	-36,800	--
Fair Value Change Income	12.1M	1.4M	52,300	1.7M	4.2M	313,600	--	--	--	--	--
Asset Disposal Income	--	--	-1,900	-53,400	--	--	-31,800	-8,300	-10,000	-105,400	--
Asset Impairment Loss	9.0M	3.9M	2.7M	1.8M	1.1M	713,200	186,300	-33,400	647,500	1.6M	-62,700
Other Income	10.4M	6.2M	5.8M	2.7M	4.2M	4.2M	8.0M	5.3M	--	--	--
Income Before Tax	172.0M	121.0M	113.0M	119.0M	118.0M	154.0M	131.0M	126.0M	90.5M	72.1M	52.6M
Income Tax	26.9M	12.3M	18.4M	18.6M	17.8M	26.0M	19.2M	18.2M	16.8M	11.4M	7.7M
+Net Income	145.0M	109.0M	94.4M	100.0M	100.0M	128.0M	112.0M	107.0M	73.7M	60.7M	44.9M
Net Margin %	11.2%	9.4%	8.5%	9.6%	13.6%	14.5%	14.0%	15.4%	13.2%	12.2%	8.5%
Net Income Attributable	146.0M	112.0M	95.0M	101.0M	100.0M	128.0M	112.0M	107.0M	73.7M	60.7M	44.8M
Minority Interest	-1.2M	-3.1M	-596,600	-1.2M	--	--	--	3,200	36,100	57,100	40,900
Eps Basic	1.08	0.83	0.72	0.76	0.77	1.00	1.60	2.15	1.47	2.09	1.54
Eps Diluted	1.08	0.83	0.71	0.76	0.77	1.00	1.60	2.15	1.47	2.09	1.54

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014
Cash And Equivalents	247.0M	158.0M	99.8M	66.3M	75.6M	181.0M	40.4M	75.7M	73.3M	24.1M	25.4M
Trading Financial Assets	--	1.3M	1.1M	26.2M	197.0M	90.3M	--	--	--	--	--
Accounts Receivable	202.0M	188.0M	151.0M	120.0M	80.0M	94.2M	85.2M	79.5M	87.8M	76.2M	58.7M
Notes Receivable	--	--	--	2.0M	--	72.1M	67.5M	52.6M	17.0M	25.0M	24.9M
Notes And Accounts Receivable	202.0M	188.0M	151.0M	122.0M	80.0M	166.0M	153.0M	132.0M	105.0M	101.0M	83.6M
Prepayments	19.8M	18.3M	12.8M	10.6M	15.5M	16.5M	14.3M	9.7M	8.6M	6.8M	9.7M
Inventory	202.0M	171.0M	165.0M	142.0M	115.0M	115.0M	101.0M	94.4M	64.3M	63.3M	61.1M
Total Current Assets	717.0M	599.0M	470.0M	465.0M	501.0M	823.0M	318.0M	319.0M	257.0M	206.0M	188.0M
Fixed Assets	--	977.0M	623.0M	551.0M	260.0M	279.0M	213.0M	204.0M	--	--	118.0M
Fixed Assets Total	1.3B	977.0M	623.0M	551.0M	260.0M	279.0M	213.0M	204.0M	207.0M	128.0M	118.0M
Construction In Progress	--	474.0M	804.0M	638.0M	667.0M	207.0M	153.0M	98.4M	25.8M	49.1M	28.6M
Construction In Progress Total	129.0M	495.0M	835.0M	643.0M	681.0M	221.0M	156.0M	101.0M	28.2M	54.0M	36.9M
Intangible Assets	112.0M	98.4M	93.5M	77.5M	78.5M	80.1M	42.5M	42.4M	43.1M	44.1M	44.6M
Long Term Deferred Expenses	282,900	348,900	1.3M	2.4M	3.4M	4.2M	664,900	1.2M	1.4M	558,700	618,300
Total Non Current Assets	1.7B	1.7B	1.7B	1.4B	1.1B	635.0M	490.0M	406.0M	344.0M	282.0M	232.0M
Total Assets	2.4B	2.3B	2.1B	1.8B	1.6B	1.5B	808.0M	726.0M	600.0M	488.0M	419.0M
Short Term Borrowings	376.0M	362.0M	360.0M	171.0M	90.1M	102.0M	94.8M	85.0M	62.0M	115.0M	107.0M
Accounts Payable	98.8M	106.0M	125.0M	144.0M	168.0M	68.9M	55.8M	71.2M	60.5M	37.8M	39.0M
Advance Receipts	--	--	--	--	--	5.2M	6.2M	4.2M	5.5M	5.5M	1.6M
Contract Liabilities	5.4M	8.0M	9.1M	16.3M	7.7M	--	--	--	--	--	--
Total Current Liabilities	596.0M	558.0M	580.0M	423.0M	308.0M	199.0M	181.0M	176.0M	146.0M	192.0M	179.0M
Long Term Borrowings	35.0M	85.3M	40.0M	--	11.4M	--	--	--	120,700	327,700	--
Total Non Current Liabilities	76.8M	128.0M	75.7M	33.3M	29.1M	18.1M	12.9M	16.3M	10.3M	611,700	135,600
Total Liabilities	673.0M	686.0M	656.0M	456.0M	337.0M	217.0M	194.0M	193.0M	156.0M	193.0M	179.0M
Paid In Capital	135.0M	135.0M	135.0M	135.0M	131.0M	93.3M	50.0M	50.0M	45.8M	26.6M	26.6M
Capital Reserve	943.0M	941.0M	930.0M	908.0M	842.0M	880.0M	384.0M	384.0M	104.0M	--	--
Surplus Reserve	67.7M	61.0M	60.8M	58.1M	46.7M	36.4M	23.4M	11.8M	22.2M	14.8M	14.8M
Retained Earnings	556.0M	457.0M	383.0M	331.0M	280.0M	232.0M	157.0M	86.6M	272.0M	253.0M	198.0M
Minority Equity	6.3M	8.3M	2.1M	2.7M	--	--	--	--	373,800	337,800	355,700
Equity Attributable	1.7B	1.6B	1.5B	1.4B	1.3B	1.2B	615.0M	533.0M	444.0M	294.0M	240.0M
Total Equity	1.7B	1.6B	1.5B	1.4B	1.3B	1.2B	615.0M	533.0M	444.0M	294.0M	240.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014
Cash From Sales	1.1B	865.0M	779.0M	673.0M	519.0M	668.0M	587.0M	446.0M	403.0M	360.0M	342.0M
Tax Refunds Received	13.4M	9.0M	41.9M	53.9M	7.0M	252,100	45,800	--	--	445,900	906,200
Total Operating Cash Inflow	1.1B	894.0M	829.0M	732.0M	532.0M	673.0M	591.0M	461.0M	419.0M	376.0M	353.0M
Cash Paid For Goods	581.0M	507.0M	489.0M	488.0M	234.0M	324.0M	348.0M	234.0M	146.0M	174.0M	180.0M
Cash Paid To Employees	137.0M	124.0M	120.0M	102.0M	80.7M	82.2M	65.6M	53.6M	41.2M	33.8M	27.7M
Taxes Paid	83.4M	61.2M	38.9M	79.1M	50.5M	62.4M	50.8M	57.7M	50.7M	31.3M	23.5M
Total Operating Cash Outflow	878.0M	774.0M	720.0M	743.0M	439.0M	543.0M	527.0M	390.0M	291.0M	294.0M	279.0M
Operating Cash Flow	222.0M	120.0M	109.0M	-11.5M	93.3M	130.0M	63.8M	71.3M	128.0M	81.1M	74.6M
Total Investing Cash Inflow	10.0M	6.2M	31.2M	218.0M	1.2B	536.0M	704,500	662,000	1.0M	5.6M	27,700
Total Investing Cash Outflow	80.5M	74.1M	269.0M	286.0M	1.3B	1.0B	77.1M	63.4M	70.8M	77.9M	88.6M
Investing Cash Flow	-70.5M	-67.8M	-238.0M	-68.0M	-165.0M	-496.0M	-76.4M	-62.8M	-69.8M	-72.3M	-88.5M
Cash From Borrowings	381.0M	483.0M	481.0M	220.0M	137.0M	133.0M	147.0M	95.0M	77.0M	134.0M	165.0M
Dividends And Interest Paid	55.5M	53.4M	51.9M	45.3M	47.1M	44.9M	35.3M	21.4M	52.1M	14.1M	13.5M
Debt Repayments	378.0M	425.0M	261.0M	155.0M	123.0M	125.0M	137.0M	72.0M	130.0M	126.0M	149.0M
Total Financing Cash Inflow	381.0M	492.0M	483.0M	273.0M	138.0M	689.0M	151.0M	97.4M	178.0M	142.0M	179.0M
Total Financing Cash Outflow	444.0M	488.0M	322.0M	203.0M	170.0M	180.0M	176.0M	101.0M	182.0M	149.0M	176.0M
Financing Cash Flow	-63.0M	4.8M	161.0M	70.6M	-32.6M	509.0M	-24.6M	-3.1M	-4.0M	-6.9M	2.5M
Net Change In Cash	89.7M	57.7M	33.6M	-9.3M	-105.0M	143.0M	-37.7M	4.2M	55.4M	2.0M	-11.4M
Ending Cash Balance	247.0M	158.0M	99.8M	66.3M	75.6M	181.0M	37.6M	75.3M	71.1M	15.7M	13.7M
Capex	51.5M	73.1M	234.0M	236.0M	282.0M	121.0M	76.9M	63.4M	69.3M	76.9M	88.5M